Pharmaceutical Compositions For Treating Cancer

Patent No. EP2105135 (titled "Pharmaceutical Compositions For Treating Cancer") was filed by Celgene on May 16, 2003. The application was issued on Oct 22, 2014.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2105135

CELGENE
Application Number
EP09008756A
Filing Date
May 16, 2003
Status
Revoked
Apr 15, 2019
Publication Date
Oct 22, 2014